Genmab Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,715	1,380	2,201	1,424	1,370
Short-Term Investments	-	1,574	1,965	1,789	1,588
Cash & Short-Term Investments	1,715	2,954	4,166	3,213	2,957
Cash Growth	-41.94%	-29.09%	29.65%	8.65%	12.04%
Accounts Receivable	22	7	9.18	6.91	514.9
Other Receivables	40	14	-	26.2	4.74
Total Trade Receivables	62	21	9.18	33.1	519.64
Inventory	18	9	8.44	-	-
Total Current Assets	2,885	3,900	4,907	4,061	3,477
Net Property, Plant & Equipment	280	265	242.97	190.28	149.1
Other Intangible Assets	9,123	1,728	14.95	21.01	38.84
Goodwill	355	355	-	-	-
Long-Term Investments	37	32	19.84	19.14	56.74
Other Long-Term Assets	171	127	31.39	36.27	44.5
Total Assets	12,873	6,414	5,225	4,335	3,766
Accrued Expenses	1,074	494	346.76	248.57	226.33
Current Portion of Leases	-	-	-	-	9.48
Unearned Revenue	119	70	75.96	73.84	3.98
Other Current Liabilities	43	239	8	-	-
Total Current Liabilities	1,427	744	367.79	262.39	239.79
Long-Term Debt	5,274	-	-	-	-
Long-Term Leases	152	144	114.01	85.93	55.51
Other Long-Term Liabilities	364	330	-	-	76.46
Total Long-Term Liabilities	5,599	533	176.94	145.95	131.98
Total Liabilities	7,026	1,277	544.72	408.34	371.76
Common Stock	10	10	9.77	9.5	10.09
Additional Paid-in Capital	1,920	1,961	1,845	1,772	1,840
Accumulated Other Comprehensive Income	-181	-226	8.88	14.11	12.39
Retained Earnings	4,098	3,392	2,817	2,131	1,532
Shareholders' Equity	5,847	5,137	4,680	3,927	3,394
Total Liabilities & Equity	12,873	6,414	5,225	4,335	3,766

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q